Search
Botanix is a medical dermatology company.

Botanix in $15m raising

Medical dermatology company Botanix Pharmaceuticals has raised $15 million through a strongly supported share placement, with the proceeds set to be spent on developing its lead product for acne.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/03/20

1 year TSR5 year TSR
34thResApp Health127%85%
264thMustera Property Group-3%2%
338thProteomics International Laboratories-17%
793rdBotanix Pharmaceuticals-80%-2%
798thDXN-82%
669 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

21/02/20
$0 Other
11/12/19
$27k Other
18/07/19
$0 Issued
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

93rd↑Botanix Pharmaceuticals$4.7m
101st↓Mustera Property Group$3.1m
104th↑ResApp Health$2.7m
106th↑Proteomics International Laboratories$2.7m
108th-DXN$2.6m
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®